This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
We must recognise and protect the pipelines that lead from research to real-worl...
Jørgensen’s ousting unusual for group where CEOs have had smooth transitions aft...
If successful, it would be the first new class of drug against certain bacteria ...
The Enhanced Games spotlight a growing interest in drugs to improve performance
He who understands it, earns it. He who doesn’t, pays it
The pharma hub stands to lose a lot in the US president’s second term
Companies riding on one big idea should use the good times to plan their next move
Being spliced on to Regeneron will free the genetic testing company from its fat...
WHO agreement aims to close resource gaps that undermined Covid response
Generics maker Sandoz says president should focus on tactic of ‘evergreening’ pr...
Law firms continue to recruit rainmakers with outsized paydays despite dealmakin...
Drugmaker’s takeover could raise privacy concerns among genetics start-up’s 15mn...
Drugmaker’s takeover comes less than two months after start-up filed for protection
Xellia Pharmaceuticals to close Copenhagen plant and shift some production to China
Vas Narasimhan argues potential US tariffs on pharma industry are not ‘sensible’
Wegovy maker expects second-half rise in business that used to go to pharmacies’...
Passionate feminist who successfully took on the pharmaceutical industry
The entrepreneur’s London penthouse is filled with bitcoin-inspired artworks, tr...
Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new l...
Danish maker of obesity drugs says new leadership is needed
Danish maker of obesity drugs says that new leadership is needed
Child suffering from rare liver disease shows improved health after treatment
Nice urges NHS to speed up distribution of approved medicines, showing economic ...
Danish company has had some poor results for new drugs designed to replace treat...